Novozymes Brasil

www.bioblog.com.br

This is cpmpany about the biotechnology company in Brazil.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Medical

CONTROLANT NOW PROVIDING MONITORING AND SUPPLY CHAIN VISIBILITY FOR PFIZER-BIONTECH COVID-19 VACCINE'S GLOBAL DISTRIBUTION

Controlant | December 16, 2020

news image

Controlant, an leader in real-time supply chain monitoring and perceivability technologies for vigorously controlled ventures, for example, pharmaceuticals and life sciences and food and drink areas, today reported it is giving observing and Supply Chain Visibility administrations to Pfizer, comparable to the conveyance of Pfizer's mRNA-based Pfizer-BioNTech COVID-19 vaccine's worldwide circulation. In addition to the visibility and monitoring arrangements that Controlant ...

Read More

Industrial Impact, Medical

PHARMING ANNOUNCES THE FIRST COMMERCIAL SHIPMENTS OF JOENJA® (LENIOLISIB) TO PATIENTS IN THE U.S.

Prnewswire | April 11, 2023

news image

Pharming Group N.V. announces the first commercial shipments of Joenja® to patients in the United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only treatment approved in the U.S. for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare and progressive primary immunodeficiency, in adult and pediatric patients 12 years of age and older. Under the terms of Pharming's 2019 exclusive license agreement with Novartis...

Read More

Cell and Gene Therapy

SPATIAL BIOLOGY CRO FLAGSHIP BIOSCIENCES ACQUIRES PHARMA SERVICES BUSINESS FROM INTERPACE BIOSCIENCES

Flagship Biosciences, Inc. | September 01, 2022

news image

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions. This acquisition follows a growth equity investment in Flagship from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies. The strategic combination of Flagship and IPS creates a full repert...

Read More

MedTech, Industrial Impact

TWIST BIOSCIENCE ANNOUNCES TECHNOLOGY EARLY ACCESS OF EWGS SOLUTION

Twist Bioscience Corporation | February 13, 2023

news image

Twist Bioscience Corporation, a company that helps customers succeed by providing high-quality synthetic DNA on its silicon platform, recently announced technology early access to the Twist enhanced Whole Genome Sequencing (eWGS) solution for applications related to non-human gnomics at the Advances in Genome Biology and Technology 2023 General Meeting conducted in Hollywood, Florida. eWGS is a unique solution that allows researchers to collect simultaneous low-pass whole genome data as we...

Read More
news image

Medical

CONTROLANT NOW PROVIDING MONITORING AND SUPPLY CHAIN VISIBILITY FOR PFIZER-BIONTECH COVID-19 VACCINE'S GLOBAL DISTRIBUTION

Controlant | December 16, 2020

Controlant, an leader in real-time supply chain monitoring and perceivability technologies for vigorously controlled ventures, for example, pharmaceuticals and life sciences and food and drink areas, today reported it is giving observing and Supply Chain Visibility administrations to Pfizer, comparable to the conveyance of Pfizer's mRNA-based Pfizer-BioNTech COVID-19 vaccine's worldwide circulation. In addition to the visibility and monitoring arrangements that Controlant ...

Read More
news image

Industrial Impact, Medical

PHARMING ANNOUNCES THE FIRST COMMERCIAL SHIPMENTS OF JOENJA® (LENIOLISIB) TO PATIENTS IN THE U.S.

Prnewswire | April 11, 2023

Pharming Group N.V. announces the first commercial shipments of Joenja® to patients in the United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only treatment approved in the U.S. for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare and progressive primary immunodeficiency, in adult and pediatric patients 12 years of age and older. Under the terms of Pharming's 2019 exclusive license agreement with Novartis...

Read More
news image

Cell and Gene Therapy

SPATIAL BIOLOGY CRO FLAGSHIP BIOSCIENCES ACQUIRES PHARMA SERVICES BUSINESS FROM INTERPACE BIOSCIENCES

Flagship Biosciences, Inc. | September 01, 2022

Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions® a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions. This acquisition follows a growth equity investment in Flagship from Ampersand Capital Partners, BroadOak Capital Partners, and Research Corporation Technologies. The strategic combination of Flagship and IPS creates a full repert...

Read More
news image

MedTech, Industrial Impact

TWIST BIOSCIENCE ANNOUNCES TECHNOLOGY EARLY ACCESS OF EWGS SOLUTION

Twist Bioscience Corporation | February 13, 2023

Twist Bioscience Corporation, a company that helps customers succeed by providing high-quality synthetic DNA on its silicon platform, recently announced technology early access to the Twist enhanced Whole Genome Sequencing (eWGS) solution for applications related to non-human gnomics at the Advances in Genome Biology and Technology 2023 General Meeting conducted in Hollywood, Florida. eWGS is a unique solution that allows researchers to collect simultaneous low-pass whole genome data as we...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us